• Friday, Sep 25, 2020
  • Last Update : 06:02 pm

Approval of Covid-19 vaccines in US unlikely before November

  • Published at 09:52 am August 14th, 2020
Flie photo_Covid-19 vaccine_Reuters_14.08.2020

NIH Director Francis Collins says testing a vaccine in at least 10,000 people could potentially give enough evidence of safety for wider use

Any potential Covid-19 vaccine backed by the Trump administration’s “Operation Warp Speed” program is unlikely to receive a green light from regulators any earlier than November or December, given the time needed for a large-scale clinical trial, the National Institutes of Health director said on Thursday.

In a call with reporters, Francis Collins said he thinks testing a vaccine in at least 10,000 people could potentially give enough evidence of safety and efficacy to clear it for wider use. US late-stage vaccine trials launched so far aim to recruit up to 30,000 people.

“I would not expect to see, on the basis of what we know scientifically, that we would be at the point where the FDA could make such a judgment until considerably later than October 1st,” Collins said, referring to the US Food and Drug Administration. “Maybe November or December would be my best bet.”

Also Read - WHO in talks with Russia on Covid-19 vaccine

He added that he is confident that at least one of the six vaccines funded by the initiative will be shown to be safe and effective by the end of the year.

President Donald Trump said last week it was possible the US would have a coronavirus vaccine before the November 3 election, a more optimistic forecast on timing than anything suggested by his own White House health experts.

Collins expects that the first tens of millions of doses of vaccine produced in the US will be allocated to those most in need, such as patients at higher risk of complications or frontline healthcare workers.

Also Read - Health Minister: Decision on collecting Covid-19 vaccine, human trial of Chinese shot soon

The US government has helped finance the development of several vaccines and therapies through the program aimed at accelerating access to medicines to fight Covid-19.

US public health officials last month charged a group of independent scientists and ethicists with developing guidelines to determine who should get the first doses of a vaccine, once one becomes available.

blogger sharing button blogger
buffer sharing button buffer
diaspora sharing button diaspora
digg sharing button digg
douban sharing button douban
email sharing button email
evernote sharing button evernote
flipboard sharing button flipboard
pocket sharing button getpocket
github sharing button github
gmail sharing button gmail
googlebookmarks sharing button googlebookmarks
hackernews sharing button hackernews
instapaper sharing button instapaper
line sharing button line
linkedin sharing button linkedin
livejournal sharing button livejournal
mailru sharing button mailru
medium sharing button medium
meneame sharing button meneame
messenger sharing button messenger
odnoklassniki sharing button odnoklassniki
pinterest sharing button pinterest
print sharing button print
qzone sharing button qzone
reddit sharing button reddit
refind sharing button refind
renren sharing button renren
skype sharing button skype
snapchat sharing button snapchat
surfingbird sharing button surfingbird
telegram sharing button telegram
tumblr sharing button tumblr
twitter sharing button twitter
vk sharing button vk
wechat sharing button wechat
weibo sharing button weibo
whatsapp sharing button whatsapp
wordpress sharing button wordpress
xing sharing button xing
yahoomail sharing button yahoomail